Search research articles
Contact Us
Filters
Showing results (181-190 of 241) with videos related to
Page
of 25
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 27, 2005
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib
David A Eberhard, Bruce E Johnson, Lukas C Amler, et al.
Biorxiv : the Preprint Server for Biology
|
July 10, 2023
A cellular and spatial atlas of <i>TP53</i> -associated tissue remodeling in lung adenocarcinoma
William Zhao, Benjamin Kepecs, Navin R Mahadevan, et al.
Nature Genetics
|
March 2, 2021
Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion
Chris J Frangieh, Johannes C Melms, Pratiksha I Thakore, et al.
Future Oncology (London, England)
|
February 15, 2024
A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small-cell lung cancer
Gregory J Riely, Egbert F Smit, Myung-Ju Ahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2005
Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology
Roy S Herbst, Dean F Bajorin, Harry Bleiberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 4, 2023
Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With
Gregory J Riely, Egbert F Smit, Myung-Ju Ahn, et al.
Cancer
|
May 12, 2026
The American Cancer Society National Lung Cancer Roundtable strategic plan: Challenges in clinical guideline recommendations for biomarker testing in lung cancer
Shetal A Patel, Jonathan L Heald, Michael Nead, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2025
Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non-Small Cell Lung Cancer
Federica Pecci, Rohit Thummalapalli, Stephanie L Alden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2023
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial
Daniel S W Tan, Enriqueta Felip, Gilberto de Castro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 2022
Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program
Brittany L Bychkovsky, Tianyu Li, Jilliane Sotelo, et al.
Page
of 25
Search research articles
Search
Showing results (181-190 of 241) with videos related to
Sort By:
Page
of 25
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 27, 2005
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib
David A Eberhard, Bruce E Johnson, Lukas C Amler, et al.
Biorxiv : the Preprint Server for Biology
|
July 10, 2023
A cellular and spatial atlas of <i>TP53</i> -associated tissue remodeling in lung adenocarcinoma
William Zhao, Benjamin Kepecs, Navin R Mahadevan, et al.
Nature Genetics
|
March 2, 2021
Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion
Chris J Frangieh, Johannes C Melms, Pratiksha I Thakore, et al.
Future Oncology (London, England)
|
February 15, 2024
A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small-cell lung cancer
Gregory J Riely, Egbert F Smit, Myung-Ju Ahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2005
Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology
Roy S Herbst, Dean F Bajorin, Harry Bleiberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 4, 2023
Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients With
Gregory J Riely, Egbert F Smit, Myung-Ju Ahn, et al.
Cancer
|
May 12, 2026
The American Cancer Society National Lung Cancer Roundtable strategic plan: Challenges in clinical guideline recommendations for biomarker testing in lung cancer
Shetal A Patel, Jonathan L Heald, Michael Nead, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 18, 2025
Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non-Small Cell Lung Cancer
Federica Pecci, Rohit Thummalapalli, Stephanie L Alden, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2023
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results From the CANOPY-1 Trial
Daniel S W Tan, Enriqueta Felip, Gilberto de Castro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 2022
Identification and Management of Pathogenic Variants in BRCA1, BRCA2, and PALB2 in a Tumor-Only Genomic Testing Program
Brittany L Bychkovsky, Tianyu Li, Jilliane Sotelo, et al.
Page
of 25